icon-    folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections (CROI)
February 22-25, 2016, Boston MA
Back grey_arrow_rt.gif
 
 
 
Attachment Inhibitor Prodrug BMS-663068 in Antiretroviral-Experienced Subjects: Week 96 Analysis
 
 
  Reported by Jules Levin
CROI 2016 Feb 22-24 Boston
 
E DeJesus,1 M Martins,2 A Stoehr,3 JA Villanueva,4 N Zakharova,5 DA Stock,6 C Llamoso,6 SR Joshi,6 GJ Hanna,7 M Lataillade6
1. Orlando Immunology Center, Orlando, FL, USA; 2. Instituto Oulton, Cordoba, Argentina;
3. IFI Institute for Interdisciplinary Medicine, Asklepios Klinik St Georg, Hamburg, Germany;4. HIV Unit, Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara, Mexico; 5. Saint-Petersburg GUZ Center of AIDS, St Petersburg, Russian Federation;6. Bristol-Myers Squibb, Research and Development, Wallingford, CT, USA; 7. Bristol-Myers Squibb, Research and Development, Princeton, NJ, USA

CROI1

CROI2

CROI3

CROI4

CROI5

CROI6

CROI7

CROI8